- Home
- STRO vs CVM Comparison
STRO vs CVM Comparison
Compare STRO & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- CVM
- Stock Information
- Founded
- STRO 2003
- CVM 1983
- Country
- STRO United States
- CVM United States
- Employees
- STRO N/A
- CVM N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- CVM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- STRO Health Care
- CVM Health Care
- Exchange
- STRO Nasdaq
- CVM Nasdaq
- Market Cap
- STRO 74.3M
- CVM 71.2M
- IPO Year
- STRO 2018
- CVM 1987
- Fundamental
- Price
- STRO $0.89
- CVM $9.99
- Analyst Decision
- STRO Hold
- CVM
- Analyst Count
- STRO 7
- CVM 0
- Target Price
- STRO $1.97
- CVM N/A
- AVG Volume (30 Days)
- STRO 598.8K
- CVM 303.9K
- Earning Date
- STRO 11-12-2025
- CVM 08-14-2025
- Dividend Yield
- STRO N/A
- CVM N/A
- EPS Growth
- STRO N/A
- CVM N/A
- EPS
- STRO N/A
- CVM N/A
- Revenue
- STRO $104,473,000.00
- CVM N/A
- Revenue This Year
- STRO $65.42
- CVM N/A
- Revenue Next Year
- STRO N/A
- CVM N/A
- P/E Ratio
- STRO N/A
- CVM N/A
- Revenue Growth
- STRO N/A
- CVM N/A
- 52 Week Low
- STRO $0.52
- CVM $1.98
- 52 Week High
- STRO $4.80
- CVM $39.30
- Technical
- Relative Strength Index (RSI)
- STRO 48.52
- CVM 51.70
- Support Level
- STRO $0.85
- CVM $9.58
- Resistance Level
- STRO $1.01
- CVM $10.48
- Average True Range (ATR)
- STRO 0.09
- CVM 1.25
- MACD
- STRO -0.01
- CVM -0.28
- Stochastic Oscillator
- STRO 16.57
- CVM 25.98
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About CVM Cel-Sci Corporation
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development of the treatment of cancer and other diseases using the immune system. The Company's core capabilities include drug discovery, research, development, and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.